BIARYL ETHER UREA COMPOUNDS

BIARYL ETHER UREA COMPOUNDS

A compound of the formula (I) (values R1, R2, R3, R4, R5, Z1, Z2, n, m and p are defined in the description) or a pharmaceutically acceptable salt thereof, a pharmaceutical composition containing it and use pharmaceutical or the pharmaceutically acceptable salt thereof for treatment of diseases or c...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: FAY, LORRAINE, KATHLEEN, WANG, LIJUAN, JANE, MEYERS, MARVIN, JAY, JOHNSON, DOUGLAS, SCOTT, LAZERWITH, SCOTT, EDWARD, MORRIS, MARK, ANTHONY, KESTEN, SUZANNE, ROSS, STIFF, CORY, MICHAEL
Format: Patent
Sprache:eng
Schlagworte:
CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator FAY, LORRAINE, KATHLEEN
WANG, LIJUAN, JANE
MEYERS, MARVIN, JAY
JOHNSON, DOUGLAS, SCOTT
LAZERWITH, SCOTT, EDWARD
MORRIS, MARK, ANTHONY
KESTEN, SUZANNE, ROSS
STIFF, CORY, MICHAEL
description A compound of the formula (I) (values R1, R2, R3, R4, R5, Z1, Z2, n, m and p are defined in the description) or a pharmaceutically acceptable salt thereof, a pharmaceutical composition containing it and use pharmaceutical or the pharmaceutically acceptable salt thereof for treatment of diseases or conditions associated with fatty acid amide hydrolase (FAAH) activity.
format Patent
fullrecord <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_GEP20125425B</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>GEP20125425B</sourcerecordid><originalsourceid>FETCH-epo_espacenet_GEP20125425B3</originalsourceid><addsrcrecordid>eNrjZJB28nQMivRRcA3xcA1SCA1ydVRw9vcN8A_1cwnmYWBNS8wpTuWF0twMim6uIc4euqkF-fGpxQWJyal5qSXx7q4BRgaGRqYmRqZOxsSoAQBTcyCk</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>BIARYL ETHER UREA COMPOUNDS</title><source>esp@cenet</source><creator>FAY, LORRAINE, KATHLEEN ; WANG, LIJUAN, JANE ; MEYERS, MARVIN, JAY ; JOHNSON, DOUGLAS, SCOTT ; LAZERWITH, SCOTT, EDWARD ; MORRIS, MARK, ANTHONY ; KESTEN, SUZANNE, ROSS ; STIFF, CORY, MICHAEL</creator><creatorcontrib>FAY, LORRAINE, KATHLEEN ; WANG, LIJUAN, JANE ; MEYERS, MARVIN, JAY ; JOHNSON, DOUGLAS, SCOTT ; LAZERWITH, SCOTT, EDWARD ; MORRIS, MARK, ANTHONY ; KESTEN, SUZANNE, ROSS ; STIFF, CORY, MICHAEL</creatorcontrib><description>A compound of the formula (I) (values R1, R2, R3, R4, R5, Z1, Z2, n, m and p are defined in the description) or a pharmaceutically acceptable salt thereof, a pharmaceutical composition containing it and use pharmaceutical or the pharmaceutically acceptable salt thereof for treatment of diseases or conditions associated with fatty acid amide hydrolase (FAAH) activity.</description><language>eng</language><subject>CHEMISTRY ; HETEROCYCLIC COMPOUNDS ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; ORGANIC CHEMISTRY ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>2012</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20120326&amp;DB=EPODOC&amp;CC=GE&amp;NR=P20125425B$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,780,885,25564,76547</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20120326&amp;DB=EPODOC&amp;CC=GE&amp;NR=P20125425B$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>FAY, LORRAINE, KATHLEEN</creatorcontrib><creatorcontrib>WANG, LIJUAN, JANE</creatorcontrib><creatorcontrib>MEYERS, MARVIN, JAY</creatorcontrib><creatorcontrib>JOHNSON, DOUGLAS, SCOTT</creatorcontrib><creatorcontrib>LAZERWITH, SCOTT, EDWARD</creatorcontrib><creatorcontrib>MORRIS, MARK, ANTHONY</creatorcontrib><creatorcontrib>KESTEN, SUZANNE, ROSS</creatorcontrib><creatorcontrib>STIFF, CORY, MICHAEL</creatorcontrib><title>BIARYL ETHER UREA COMPOUNDS</title><description>A compound of the formula (I) (values R1, R2, R3, R4, R5, Z1, Z2, n, m and p are defined in the description) or a pharmaceutically acceptable salt thereof, a pharmaceutical composition containing it and use pharmaceutical or the pharmaceutically acceptable salt thereof for treatment of diseases or conditions associated with fatty acid amide hydrolase (FAAH) activity.</description><subject>CHEMISTRY</subject><subject>HETEROCYCLIC COMPOUNDS</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2012</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZJB28nQMivRRcA3xcA1SCA1ydVRw9vcN8A_1cwnmYWBNS8wpTuWF0twMim6uIc4euqkF-fGpxQWJyal5qSXx7q4BRgaGRqYmRqZOxsSoAQBTcyCk</recordid><startdate>20120326</startdate><enddate>20120326</enddate><creator>FAY, LORRAINE, KATHLEEN</creator><creator>WANG, LIJUAN, JANE</creator><creator>MEYERS, MARVIN, JAY</creator><creator>JOHNSON, DOUGLAS, SCOTT</creator><creator>LAZERWITH, SCOTT, EDWARD</creator><creator>MORRIS, MARK, ANTHONY</creator><creator>KESTEN, SUZANNE, ROSS</creator><creator>STIFF, CORY, MICHAEL</creator><scope>EVB</scope></search><sort><creationdate>20120326</creationdate><title>BIARYL ETHER UREA COMPOUNDS</title><author>FAY, LORRAINE, KATHLEEN ; WANG, LIJUAN, JANE ; MEYERS, MARVIN, JAY ; JOHNSON, DOUGLAS, SCOTT ; LAZERWITH, SCOTT, EDWARD ; MORRIS, MARK, ANTHONY ; KESTEN, SUZANNE, ROSS ; STIFF, CORY, MICHAEL</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_GEP20125425B3</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng</language><creationdate>2012</creationdate><topic>CHEMISTRY</topic><topic>HETEROCYCLIC COMPOUNDS</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>FAY, LORRAINE, KATHLEEN</creatorcontrib><creatorcontrib>WANG, LIJUAN, JANE</creatorcontrib><creatorcontrib>MEYERS, MARVIN, JAY</creatorcontrib><creatorcontrib>JOHNSON, DOUGLAS, SCOTT</creatorcontrib><creatorcontrib>LAZERWITH, SCOTT, EDWARD</creatorcontrib><creatorcontrib>MORRIS, MARK, ANTHONY</creatorcontrib><creatorcontrib>KESTEN, SUZANNE, ROSS</creatorcontrib><creatorcontrib>STIFF, CORY, MICHAEL</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>FAY, LORRAINE, KATHLEEN</au><au>WANG, LIJUAN, JANE</au><au>MEYERS, MARVIN, JAY</au><au>JOHNSON, DOUGLAS, SCOTT</au><au>LAZERWITH, SCOTT, EDWARD</au><au>MORRIS, MARK, ANTHONY</au><au>KESTEN, SUZANNE, ROSS</au><au>STIFF, CORY, MICHAEL</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>BIARYL ETHER UREA COMPOUNDS</title><date>2012-03-26</date><risdate>2012</risdate><abstract>A compound of the formula (I) (values R1, R2, R3, R4, R5, Z1, Z2, n, m and p are defined in the description) or a pharmaceutically acceptable salt thereof, a pharmaceutical composition containing it and use pharmaceutical or the pharmaceutically acceptable salt thereof for treatment of diseases or conditions associated with fatty acid amide hydrolase (FAAH) activity.</abstract><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier
ispartof
issn
language eng
recordid cdi_epo_espacenet_GEP20125425B
source esp@cenet
subjects CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
title BIARYL ETHER UREA COMPOUNDS
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-29T12%3A29%3A29IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=FAY,%20LORRAINE,%20KATHLEEN&rft.date=2012-03-26&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EGEP20125425B%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true